Syndromic testing

Tackle respiratory infections year-round

Don’t get caught off guard this respiratory season

We’ve learned to adapt to the unexpected over the past few years. But the risk of an unexpectedly severe 2023–2024 remains a real possibility. And respiratory illness still poses a significant risk to many people in our community. That’s why it’s more important than ever to prepare your lab with the QIAstat-Dx Respiratory SARS-CoV-2 Panel.

Read on to learn how our multiplex panel tests can help you get quick, definitive answers when you need them.

PHC, personalized healthcare, doctor, scientist, oncologist, pathologist, clinical, laboratory, discussing patient care, (Person/s, Scientist/s, Photography, MDx, Doctor/Physician, Personalized health care (PHC), Hospital)

Multiplex panels can make your job easier

As cases of influenza-like illness spike this respiratory season, you and your team will be under enormous pressure. Take the stress out of diagnostics and get patients back to their families sooner with a diagnostic tool that tests for multiple circulating respiratory pathogens at once. Learn how multiplex PCR panels can save you time, improve patient outcomes and benefit your hospital as a whole. 

Learn how

Tackle antimicrobial resistance

Antimicrobial resistance (AMR) threatens the efficacy of our antimicrobials and increases the risk of common respiratory infections progressing to sepsis. Lower respiratory infections associated with AMR resulted in 1.5 million deaths in 2019 (1). But you can fight back against AMR. By rapidly and accurately diagnosing respiratory infections early, you can support evidence-based antimicrobial use. Join us this World Antimicrobial Awareness Week to help spread awareness and take control in the fight against AMR.

Learn more
QIAstat-Dx, woman, physician, child, woman, mother, mom, asian, pharmacist, infectious disease, syndromic testing
Allison Glass, lab, testing

Outrunning viruses – multiplex testing in the field

Clinical virologist, Dr. Allison Glass, thrives on fast-paced results, whether she’s running an ultramarathon or running a state-of-the-art molecular diagnostics lab. Learn how she leverages the fast results provided by multiplex panel tests to stay one step ahead of viruses.

Read her story

Explore respiratory testing resources

The answer to your respiratory testing needs

The symptoms of flu, COVID-19 and other respiratory infections are all very similar, making them difficult to diagnose. Sensitive multiplex PCR panel testing is a fast and simple way to accurately diagnose your patients when multiple respiratory pathogens are circulating. In fact, the CDC and the Academy of Medical Sciences “strongly support multiplex testing” in this situation (2, 3).

With the QIAstat-Dx Respiratory SARS-CoV-2 Panel, you don’t just get results for 23 respiratory pathogens in about an hour. You also get access to Ct values and amplification curves, powerful connectivity features and on-demand epidemiology reports.
Learn more about the QIAstat-Dx Respiratory SARS-CoV-2 Panel
* Enterovirus and Rhinovirus are both detected, but not differentiated, with the QIAstat-Dx Respiratory SARS-CoV-2 Panel.

Learn more about the QIAstat-Dx Respiratory SARS-CoV-2 Panel

QIAstat-Dx is your answer to rapid, comprehensive respiratory testing. With QIAstat-Dx, you get results for 23 common respiratory viruses and bacteria, including SARS-CoV-2, influenza and RSV, all in about an hour. Learn how the QIAstat-Dx Respiratory SARS-CoV-2 Panel can change the way you diagnose patients this respiratory season and beyond.

Download the flyer
Get in touch – we’re ready to help you
Our team of experts is ready to help you bring the reliability of QIAstat-Dx multiplex panel testing to your lab. Contact us to see how. 
Contact an expert

References

  1. Antimicrobial Resistance Collaborators (2022) Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399, 10325: 629–655
  2. Academy of Medical Sciences (2021) COVID-19: Preparing for the future – Looking ahead to winter 2021/22 and beyond. https://acmedsci.ac.uk/file-download/4747802
  3. CDC. Testing Guidance for Clinicians When SARS-CoV-2 and Influenza Viruses are Co-circulating https://www.cdc.gov/flu/professionals/diagnosis/testing-guidance-for-clinicians-hospitaized.htm

The QIAstat-Dx Analyzer and the QIAstat-Dx Respiratory SARS-CoV-2 Panel are intended for in vitro diagnostic use. 

For up-to-date licensing information and product-specific disclaimers, see the respective QIAGEN kit instructions for use or user manual. QIAGEN instructions for use and user manuals are available at www.qiagen.com or can be requested from QIAGEN Technical Services (or your local distributor).